发明名称 Eicosanoid derivatives
摘要 The present invention provides compounds (n-3 PUFA derivatives) of formula (I) that modulate conditions associated with cardiac damage, especially cardiac arrhythmias.;
申请公布号 US9272991(B2) 申请公布日期 2016.03.01
申请号 US201013144301 申请日期 2010.01.13
申请人 MAX-DELBRUECK-CENTRUM FUER MOLEKULARE MEDIZIN (MDC);BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 发明人 Schunck Wolf-Hagen;Wallukat Gerd;Fischer Robert;Arnold Cosima;Mueller Dominik N.;Puli Narender;Falck John R.
分类号 C07C275/16;C07C233/09;C07C233/49;C07C235/28;C07C275/14;C07C233/47;C07D303/38 主分类号 C07C275/16
代理机构 Agris & von Natzmer LLP 代理人 von Natzmer Joyce;Agris & von Natzmer LLP
主权项 1. A compound of the general formula (I): or a pharmacologically acceptable salt, solvate, hydrate or a pharmacologically acceptable formulation thereof, wherein R1 is selected from R2 is hydroxy, heteroalkyl, alkoxy, polyalkoxyalkyl, NR3R4, (NHS(O)2-m-(C6H4)N3, or Xaao; R3 and R4 are each and independently of each other selected from the group consisting of hydrogen atom, hydroxy, alkyl, heteroalkyl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aralkyl, or heteroaralkyl; Xaa is Gly, a conventional D,L-, D- or L-amino acid, a non-conventional D,L-, D- or L-amino acid, or a 2- to 10-mer peptide, wherein Xaa is joined to —C(O) by an amide bond; o is an integer selected from 1 to 10; B is CH2, 0, or S; m is an integer from 1 to 6; T, U, and W are each —CH2CH2—; V is cis or trans —CH═CH—; X is absent, CH2, and NR5; Z is selected from CH2, and NR5′; R5 and R5′ are each and independently of each other selected from the group consisting a hydrogen atom, a hydroxy, alkyl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aralkyl, heteroaralkyl group; Y is —C(O)—, —C(O)—C(O)—, or —S—; and n is an integer from 0 to 6.
地址 Berlin DE